These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30643458)

  • 1. Identification of hub genes and outcome in colon cancer based on bioinformatics analysis.
    Yang W; Ma J; Zhou W; Li Z; Zhou X; Cao B; Zhang Y; Liu J; Yang Z; Zhang H; Zhao Q; Hong L; Fan D
    Cancer Manag Res; 2019; 11():323-338. PubMed ID: 30643458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of core genes and outcome in gastric cancer using bioinformatics analysis.
    Sun C; Yuan Q; Wu D; Meng X; Wang B
    Oncotarget; 2017 Sep; 8(41):70271-70280. PubMed ID: 29050278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential core genes in gastric cancer using bioinformatics analysis.
    Shao C; Wang R; Kong D; Gao Q; Xu C
    J Gastrointest Oncol; 2021 Oct; 12(5):2109-2122. PubMed ID: 34790378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis.
    Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G
    Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
    Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
    Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis.
    Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX
    Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
    Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
    Front Genet; 2020; 11():530892. PubMed ID: 33061942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
    Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
    PeerJ; 2018; 6():e5180. PubMed ID: 30002985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hub genes associated with outcome of clear cell renal cell carcinoma.
    Li R; Wang L; Wang X; Geng RX; Li N; Liu XH
    Oncol Lett; 2020 Apr; 19(4):2846-2860. PubMed ID: 32218839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
    Zhou L; Du Y; Kong L; Zhang X; Chen Q
    Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
    Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
    Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of hub genes in colon cancer via bioinformatics analysis.
    Liu J; Sun GL; Pan SL; Qin MB; Ouyang R; Huang JA
    J Int Med Res; 2020 Sep; 48(9):300060520953234. PubMed ID: 32961078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of genes and pathways in esophageal adenocarcinoma using bioinformatics analysis.
    He F; Ai B; Tian L
    Biomed Rep; 2018 Oct; 9(4):305-312. PubMed ID: 30233782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.